Goud et al. write [1]:
"because dose optimization is currently based on patients’ report of symptoms, which are difficult for patients to describe, the management of PD is challenging. We report on a microneedle sensing platform for continuous minimally invasive orthogonal electrochemical monitoring of levodopa (L-Dopa)"
I have not found how we can get hold of this equipment.
But, as a possible way forward, I notice how cheap glucose monitors have become (about £10 on ebay). I see that these could be used in two different ways. First directly, to measure glucose levels throughout the levodopa cycle (typically about 3 to 4 hours from dose to dose). Secondly indirectly, given the suggested connection between glucose and levodopa [2], it may be possible to use glucose as a proxy for levodopa.
"Insulin resistance (IR) is a precursor to type-2 diabetes (T2D) – a disease that occurs when your blood glucose (blood sugar) is too high. First suggested in the 1960s, a growing number of studies are finding links between Parkinson's disease (PD) and T2D."
References
[1] "Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson Management", K. Yugender Goud et al.
[2] parkinson.org/blog/science-....
John